Profile photo Miedema

Miedema

Full Professor

Biography

Frank Miedema studied biochemistry at the University of Groningen, specializing in immunology. As Division Manager at the Central Laboratory of the Blood Transfusion Service (CLB) he was responsible for such things as education and research, before going on to become Director of Sanquin Research. Miedema was affiliated with the University of Amsterdam as professor of Immunology of AIDS. In 2004 he became head of the Immunology department at UMC Utrecht. from 2009-2019 he was dean and vice chair of the board of  UMC Utrecht. Since then vice rector for research at UU/UMCU. He is one of the initiators of www.scienceintransition.com. The initiators of Science in Transition believe that the scientific system is in need of fundamental reform. Science should be appreciated for the added value it contributes to society and stakeholders in society must participate in decisions regarding the production of knowledge.

Recent publications

De universiteit in transitie Henk Kummeling, Manon Kluijtmans, F Miedema
2023
Prepare PhD holders for different career tracks Theo van den Broek, Berent Prakken, Frank Miedema
Nature, 2021, vol. 600, p.386
Reshaping the Academic Self: Connecting Education & Open Science Sicco De Knegt, Martijn van der Meer, Loek Brinkman, Manon Kluijtmans, Frank Miedema
2021
Visualisation of Manifesto - Reshaping the Academic Self: Connecting Education & Open Science Sicco De Knegt, Martijn University, Loek Brinkman, Manon Kluijtmans, Frank Miedema
2021
Toll-like receptor 7-adapter complex modulates interferon-α production in HIV-stimulated plasmacytoid dendritic cells Andy A Patamawenu, Nathaniel E Wright, Tulley Shofner, Sean Evans, Maura M Manion, Nicole Doria-Rose, Stephen A Migueles, Daniel Mendoza, Bennett Peterson, Christopher Wilhelm, Julia Rood, Amy Berkley, Nancy A Cogliano, C Jason Liang, Kiki Tesselaar, Frank Miedema, Julian Bess, Jeffrey Lifson, Mark Connors
PLoS ONE, 2019, vol. 14
Immunometabolic signatures predict risk of progression to active tuberculosis and disease outcome Fergal J. Duffy, January Weiner, Scott Hansen, David L. Tabb, Sara Suliman, Ethan Thompson, Jeroen Maertzdorf, Smitha Shankar, Gerard Tromp, Shreemanta Parida, Drew Dover, Michael K. Axthelm, Jayne S. Sutherland, Hazel M. Dockrell, Tom H.M. Ottenhoff, Thomas J. Scriba, Louis J. Picker, Gerhard Walzl, Stefan H.E. Kaufmann, Daniel E. Zak, R. Golinski, M. Jacobson, G. McEwen, G. Walzl, G. F. Black, G. Van Der Spuy, K. Stanley, M. Kriel, N. DuPlessis, N. Nene, A. G. Loxton, N. N. Chegou, M. Fisher, H. Mahomed, J. Hughes, K. Downing, A. Penn-Nicholson, H. Mulenga, B. Abel, M. Bowmaker, B. Kagina, W. Kwong, C. W. Hanekom, M. R. Klein, M. C. Haks, K. L. F ranken, D. Van Baarle, F. Miedema, B. Thiel, S. Muller,
Frontiers in Immunology, 2019, vol. 10, p.527